Cyclacel Pharmaceuticals Files 2024 10-K, Details Warrant Activity
Ticker: BGMSP · Form: 10-K · Filed: Apr 2, 2025 · CIK: 1130166
Sentiment: neutral
Topics: 10-K, pharmaceuticals, warrants, financials
Related Tickers: CYCC
TL;DR
CYCC 2024 10-K is in. Lots of warrant activity noted, check dilution.
AI Summary
Cyclacel Pharmaceuticals, Inc. filed its 10-K for the fiscal year ending December 31, 2024. The company, formerly known as XCYTE THERAPIES INC, is incorporated in Delaware and operates in the pharmaceutical preparations sector. The filing details its business address in Berkeley Heights, NJ, and provides information on various warrant agreements, including Series D, Series C, Series A, and Placement Agent Warrants, with specific dates like November 13, 2024, and December 21, 2023.
Why It Matters
This filing provides investors with a comprehensive overview of Cyclacel Pharmaceuticals' financial health and operational details for the past fiscal year, including significant warrant transactions that could impact share structure.
Risk Assessment
Risk Level: medium — The company's financial health and future prospects are subject to the inherent risks of the pharmaceutical industry, including drug development, regulatory approvals, and market competition.
Key Numbers
- 20241231 — Fiscal Year End (The period covered by the 10-K filing.)
- 20250402 — Filing Date (The date the 10-K was officially submitted to the SEC.)
Key Players & Entities
- Cyclacel Pharmaceuticals, Inc. (company) — Filer of the 10-K
- XCYTE THERAPIES INC (company) — Former name of Cyclacel Pharmaceuticals, Inc.
- 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS, NJ 07922 (location) — Business and mailing address
- November 13, 2024 (date) — Date related to Series D and Series C Warrant Exercise and Reload Agreement
- December 21, 2023 (date) — Date related to Placement Agent Warrants and Securities Purchase Agreement
FAQ
What is the primary business of Cyclacel Pharmaceuticals, Inc.?
Cyclacel Pharmaceuticals, Inc. operates in the Pharmaceutical Preparations sector, as indicated by its Standard Industrial Classification code [2834].
When was Cyclacel Pharmaceuticals, Inc. previously known by another name?
The company was formerly known as XCYTE THERAPIES INC, with a name change date of December 18, 2000.
What are some of the specific warrant agreements mentioned in the filing?
The filing mentions Series D Warrants, Series C Warrants, Series A Warrants, and Placement Agent Warrants, associated with agreements dated November 13, 2024, and December 21, 2023.
Where is Cyclacel Pharmaceuticals, Inc. located?
The company's business and mailing address is 200 CONNELL DRIVE, SUITE 1500, BERKELEY HEIGHTS, NJ 07922.
What is the SEC file number for this 10-K filing?
The SEC file number for this 10-K filing is 000-50626.
Filing Details
This Form 10-K (Form 10-K) was filed with the SEC on April 2, 2025 regarding Cyclacel Pharmaceuticals, Inc. (BGMSP).